Nepal | August 12, 2020

Plasma therapy: New hope for COVID-19

Dr Rajan Shah
Share Now:

Plasma is the clear, straw coloured liquid portion of the blood that remains after the red blood cells, white blood cells, platelets and other cellular components are removed. It comprises 55 per cent of human blood and contains antibodies that can fight against diseases.

Covalescent plasma is the plasma drawn from the people who have recovered from a disease. It is rich in antibodies and has been used to treat or prevent serious infections and been part of medical practice for more than 100 years. Before vaccines, this was successfully used for infectious diseases like diphtheria, measles, polio and mumps.

In 1918, the Spanish Flu pandemic and even recently during the SARS and EBOLA outbreaks, it helped patients to recover. Now the idea is being revived by scientists as an effective treatment for patients hospitalised with COVID-19 or those who are at higher risk of getting the virus, like health care workers.

When a person is infected with COVID-19, the body creates blood proteins called antibodies to fight against the virus. It clears the virus and maintains antibody response, which approximately lasts for a year. The plasma is collected from patients who have recovered from COVID-19 and must be free of symptoms for at least 14 days. The red and white cells are separated and put back into the donor’s blood stream while the blood plasma, rich in antibodies, is stored for transfusion.

Survivors will be able to donate only twice, 400 ml each time, possibly saving 2-3 lives. The donor and the patient must be of compatible blood types, and the plasma is then tested for multiple diseases, including COVID-19, hepatitis and HIV. Next, it is again tested to make sure it has enough antibodies to effectively treat or prevent COVID-19. After that it is infused in the recipient. Vaccines also trigger the body to produce these antibodies. But currently there is no vaccine so it remains best source of antibodies for now.

Results are promising. A study published in the Journal of the American Medical Association on March 27 shows some evidence that plasma could help people with severe illness. Researchers in China report that five critically ill patients improved after receiving covalescent plasma. An online site has also been registered in the US where COVID-19 recovered people can register and donate their blood. Even the FDA has approved it for experimental trials. Besides China, Israel and the US have started to get positive results from the therapy. However, it’s not easy to find enough people who are eligible to donate. It is expensive and cannot be done on a large scale.

A number of drugs are now being tested in patients with COVID-19, but there is no robust evidence regarding its effectiveness. And even if a coronavirus vaccine is developed at lightning speed, it’s at least a year away. This covalescent plasma could be a vital treatment route until a better treatment, or vaccine, is available.


Follow The Himalayan Times on Twitter and Facebook

Recommended Stories:

More from The Himalayan Times:

Europa League, Shakhtar Donetsk

Four-goal Shakhtar set up Europa semi against Inter

GELSENKIRCHEN: Shakhtar Donetsk booked a clash with Inter Milan in the Europa League semi-finals after goals from Brazilians Junior Moraes, Taison, Alan Patrick and Dodo gave them a 4-1 win over FC Basel in a one-sided last-eight clash on Tuesday. The Ukrainian champions will take on In Read More...

Woman, daughter held in Gongabu murder case

Kathmandu, August 11 Nepal Police today made public the woman, who was arrested on the charge of murdering a man in Gongabu. The headless body of Krishna Bahadur Bohora, 45, of Rolpa was found inside a suitcase, around 100meters away from her rented room at Ganesthan, Gongabu on Sunday. Pol Read More...

COVID-19 likely to persist until India gets rid of it: Health Minister

Kathmandu, August 11 Minister of Health and Population Bhanubhakta Dhakal has said the risk of COVID-19 will remain in Nepal until the pandemic is totally contained in India. Addressing the 61st Anniversary Programme of Paropakar Maternity and Gynaecology Hospital here today, he argued that as Read More...

Bajura village cut off from rest of Nepal

BAJURA, AUGUST 11 Ajaytodki village in Ward 2 of Gaumul Rural Municipality in Bajura has been cut-off from the rest of the country for the past two days after the swollen Budhiganga River swept away a bailey bridge at Jadanga along the Sanfe-Martadi road. The sweeping away of the bridge has disco Read More...

Informal, salaried workers hit hard by COVID-19 in Kathmandu valley: Study

Kathmandu, August 11 Nearly 29 per cent of the respondents interviewed by Kathmandu Metropolitan City in a survey on ‘Impact of COVID-19 on Livelihood’ said their families were stressed due to the uncertain future facing them in the metropolis. Families living in rented rooms or houses sai Read More...

Bharatpur Hospital

Human resource crunch hits COVID lab

CHITWAN, AUGUST 11 Bharatpur COVID-19 laboratory built in April in a short period of time, is struggling to perform. Shortage of human resources has marred the laboratory’s service delivery. The lab established under Bharatpur Hospital has not made any visible progress compared to its initia Read More...

COVID spreads at community level in Rautahat

Rautahat, August 11 COVID-19 infection has been spreading at the community level in Rautahat. As many as 11 persons, including a youth leader, a petrol pump owner and an assistant health worker of Pothiyahi health post, have tested positive for the virus in Garuda Municipality today. It is Read More...

Democrat Joe Biden chooses US Senator Kamala Harris for White House running mate

Democratic presidential candidate Joe Biden on Tuesday picked Senator Kamala Harris as his choice for vice president, making her the first Black woman on a major-party US presidential ticket and giving him a partner well prepared to go on the attack against Republican President Donald Trump. Read More...